> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-202/
- Published: 2018-11-04T12:00:00.000Z
- Updated: 2026-09-15T00:42:21.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142746

[**Draft Guide on Hepatitis B Drugs**](https://www.fdaweb.com/draft-guide-on-hepatitis-b-drugs/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Chronic Hepatitis B Virus Infection: Developing Drugs for Treatment.” 11/02/2018 [**Workshop on Hemophilia Product Development**](https://www.fdaweb.com/workshop-on-hemophilia-product-development/)  
*Federal Register* notice: FDA announces a 12/6 public workshop entitled “Product Development in Hemophilia.” 11/02/2018 [**Class 2 for Meprobamate Test System**](https://www.fdaweb.com/class-2-for-meprobamate-test-system/)  
*Federal Register* notice: FDA classifies the meprobamate test system into Class 2 (special controls). 11/01/2018 [**Insulin Therapy Adjustment Devices into Class 2**](https://www.fdaweb.com/insulin-therapy-adjustment-devices-into-class-2/)  
*Federal Register* notice: FDA classifies insulin therapy adjustment devices into Class 2 (special controls). 11/01/2018 [**2 Medical Device Proposed Rules Scrapped**](https://www.fdaweb.com/2-medical-device-proposed-rules-scrapped/)  
*Federal Register* notice: FDA withdraws two proposed medical device rules after determining that they are not currently considered viable candidates for final action. 11/01/2018 [**FDA Science Advisory Board Meeting 12/4-5**](https://www.fdaweb.com/fda-science-advisory-board-meeting-12-4-5/)  
*Federal Register* notice: FDA announces a 12/4-5 meeting of the Science Advisory Board to the National Center for Toxicological Research. 10/31/2018 [**Information Collection Extension for Bar Code Labels**](https://www.fdaweb.com/information-collection-extension-for-bar-code-labels/)  
*Federal Register* notice: FDA seeks comments on an information collection extension entitled “Bar Code Label Requirement for Human Drug and Biological Products.” 10/31/2018 [**Draft Guide on Dried Plasma Products**](https://www.fdaweb.com/draft-guide-on-dried-plasma-products/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Considerations for the Development of Dried Plasma Products Intended for Transfusion.” 10/30/2018 [**10 NDA Approvals Withdrawn by FDA**](https://www.fdaweb.com/10-nda-approvals-withdrawn-by-fda/)  
*Federal Register* notice: FDA withdraws approval of 10 NDAs from multiple applicants after they notified the agency that the drug products were no longer marketed. 10/30/2018